111, Inc. ADR (YI)
NASDAQ
Closed
Aug 24, 2026
Day's Range
3.5152 wk Range
2.48Overview - YI - 111, Inc. ADR
Key Statistics
Valuation
Enterprise Value
130.33M
P/E (Trailing)
‪-0.02‬
P/E (Forward)
‪25.50‬
PEG Ratio
‪-0.00021‬
Price / Sales (TTM)
‪0.0027‬
Price / Book
‪1.14‬
EV / EBITDA
‪-73.43‬
Profitability
Gross Margin
‪5.33%‬
Profit Margin
‪-0.75%‬
Operating Margin
‪-0.84%‬
Return on Assets
‪-0.61%‬
Return on Equity
‪-14.84%‬
Ownership
Shares Outstanding
175.93M
Float
4.60M
Short % of Shares Outstanding
‪0.16%‬
Held by Insiders
‪8.36%‬
Held by Institutions
‪0.61%‬
Price stats
Beta
‪0.66‬
50-Day Avg
‪3.94‬
200-Day Avg
‪5.14‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - YI - 111, Inc. ADR
Peers - YI - 111, Inc. ADR
Peer Comparison
Compared with companies in Medical Distribution listed on NASDAQ.
Profile Summary - YI - 111, Inc. ADR
About
111, Inc. American Depositary Receipt (ADR) represents shares of 111, Inc., a Chinese healthcare company with a comprehensive online and offline platform serving the healthcare ecosystem in China. The company operates through two main segments: B2C, serving individual consumers, and B2B, catering to corporate clients…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
